Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

4 results
Display

Azasugar Nucleotide-containing Phosphorothioate Oligonucleotides as an AIDS Therapeutic Drug

Lee DS, Lim H, Bae YS

  • KMID: 1573026
  • J Bacteriol Virol.
  • 2002 Jun;32(2):165-176.
A series of modified oligonucleotides containing P=S backbone and a six-membered azasugar (6-AZS) were synthesized and tested for their ability to inhibit human immunodeficiency virus (HIV) in vitro without the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Antiviral Effect of Antisense Phosphorothioate Oligonucleotides Targeted to Herpes Simplex Virus

Lee YC, Kim SJ, Cho YJ

  • KMID: 2146905
  • J Korean Soc Microbiol.
  • 1999 Jun;34(3):233-243.
To search the effective antisense oligonucleotide that inhibit the growth of Herpes simplex virus type 1 (HSV-1), six kinds of phosphorothioate oligodeoxynucleotides (S-ODNs) were synthesized and the antiviral activity was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Targeted Therapy in Inflammatory Bowel Disease; Current Status and Future Perspectives

Jang BI

Novel biologic agents that selectively target specific molecules and pathways have been developed recently for the management of inflammatory bowel disease (IBD). Anti-TNF-alpha, an antibody to TNF-alpha is one of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of CpG-Oligodeoxynucleotides with Different Backbone Structures and 3' Hexameric Deoxyriboguanosine Run Conjugation on the Treatment of Asthma in Mice

Chang YS, Kim YK, Kwon HS, Park HW, Min KU, Kim YY, Cho SH

CpG-Oligodeoxynucleotide (ODN) has two backbones. Phosphorothioate backbone (PS) shows a strong immunostimulating effect while phosphodiester (PE) shows little in vivo. 3' hexameric deoxyriboguanosine-run (3' dG6-run) conjugation to PE CpG-ODN has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr